Sciencast Management LP Buys New Holdings in Cooper Companies Inc (COO)

Sciencast Management LP bought a new stake in Cooper Companies Inc (NYSE:COO) in the first quarter, HoldingsChannel reports. The institutional investor bought 6,352 shares of the medical device company’s stock, valued at approximately $1,837,000.

Other large investors have also made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Cooper Companies by 3.8% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,123 shares of the medical device company’s stock worth $540,000 after acquiring an additional 78 shares during the period. BTIM Corp. increased its stake in shares of Cooper Companies by 9.0% during the fourth quarter. BTIM Corp. now owns 58,798 shares of the medical device company’s stock worth $14,965,000 after acquiring an additional 4,834 shares during the period. APG Asset Management N.V. increased its stake in shares of Cooper Companies by 1.5% during the fourth quarter. APG Asset Management N.V. now owns 6,600 shares of the medical device company’s stock worth $1,469,000 after acquiring an additional 100 shares during the period. Thrivent Financial for Lutherans increased its stake in shares of Cooper Companies by 1.8% during the fourth quarter. Thrivent Financial for Lutherans now owns 2,141 shares of the medical device company’s stock worth $545,000 after acquiring an additional 37 shares during the period. Finally, Morgan Stanley increased its stake in shares of Cooper Companies by 734.7% during the third quarter. Morgan Stanley now owns 177,658 shares of the medical device company’s stock worth $49,238,000 after acquiring an additional 156,373 shares during the period.

Shares of Cooper Companies stock traded up $1.67 on Monday, reaching $294.61. 5,064 shares of the stock were exchanged, compared to its average volume of 341,923. The company has a quick ratio of 0.75, a current ratio of 1.27 and a debt-to-equity ratio of 0.49. Cooper Companies Inc has a 1-year low of $219.54 and a 1-year high of $302.36. The firm has a market cap of $14.51 billion, a price-to-earnings ratio of 25.65, a price-to-earnings-growth ratio of 2.26 and a beta of 0.88.

Cooper Companies (NYSE:COO) last issued its earnings results on Tuesday, March 5th. The medical device company reported $2.88 earnings per share for the quarter, topping the consensus estimate of $2.50 by $0.38. Cooper Companies had a net margin of 14.22% and a return on equity of 17.56%. The company had revenue of $628.10 million for the quarter, compared to analyst estimates of $618.50 million. Equities research analysts anticipate that Cooper Companies Inc will post 12.01 EPS for the current year.

In other Cooper Companies news, CFO Brian G. Andrews sold 1,648 shares of the company’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $293.28, for a total transaction of $483,325.44. Following the transaction, the chief financial officer now directly owns 1,101 shares in the company, valued at $322,901.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Gary S. Petersmeyer sold 799 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $286.88, for a total transaction of $229,217.12. The disclosure for this sale can be found here. Insiders have sold 87,030 shares of company stock worth $25,461,465 over the last 90 days. 1.70% of the stock is currently owned by company insiders.

A number of brokerages have recently issued reports on COO. Raymond James boosted their price target on shares of Cooper Companies from $300.00 to $325.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 6th. BMO Capital Markets boosted their price target on shares of Cooper Companies from $306.00 to $320.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 6th. Stephens boosted their price target on shares of Cooper Companies from $305.00 to $320.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 6th. KeyCorp boosted their price target on shares of Cooper Companies from $296.00 to $314.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 6th. Finally, Piper Jaffray Companies reiterated an “overweight” rating and set a $325.00 price target on shares of Cooper Companies in a research note on Wednesday, March 6th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $307.90.

COPYRIGHT VIOLATION NOTICE: This report was published by WKRB News and is the sole property of of WKRB News. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at https://www.wkrb13.com/2019/04/15/sciencast-management-lp-buys-new-holdings-in-cooper-companies-inc-coo.html.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Recommended Story: Quick Ratio

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.